The research about the effect of Magnesium Sulfate on vascular endothelial dysfunction, inflammation and oxidative stress in severe preeclampsia.

The research about the effect of Magnesium Sulfate on vascular endothelial dysfunction, inflammation and oxidative stress in severe preeclampsia. - The research about the effect of Magnesium Sulfate on vascular endothelial dysfunction, inflammation and oxidative stress in severe preeclampsia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013891

Enrollment

Registered

2014-06-01

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclampsia

Interventions

Intravenous administration of Magnesium sulfate

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The patients who was diagnosed with preeclampsia should be included.

Exclusion criteria

Exclusion criteria: The patients who are suffered from myasthenia gravis, cardiac block and hypotonic dehydration which are contraindication for Magnesium Sulfate should be excluded.

Design outcomes

Primary

Measure	Time frame
Maternal serum soluble fms-like tyrosine kinase 1 Maternal serum Tumor Necrosis Factor 1 Maternal urine F2-Isoprostanes	—

Countries

Japan

Contacts

Public ContactKaoru Kawasaki

Kyoto University Graduate School of Medicine Obstetrics and Gynecology

kkaoru@kuhp.kyoto-u.ac.jp075-751-3269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026